QwikAgents engages Caylent for AWS-native platform build
Silo Pharma’s wholly owned AI unit QwikAgents engaged Caylent, an AWS Premier Tier partner, to build a new AWS-native platform.
The project targets faster commercialization, improved scalability, stronger security and higher performance for enterprise deployments.
Caylent will rebuild the platform rather than migrate the existing application, preserving core functionality while enabling future product development.
The engagement is structured to align with AWS funding programs, with funding support expected from AWS and Caylent.
SILO•
